|
시장보고서
상품코드
1991352
경피 흡수형 패치 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Transdermal Skin Patches Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
경피 흡수형 패치 시장 규모는 2025년 93억 달러에서 2034년에는 150억 2,000만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 5.47%로 성장할 것으로 전망됩니다.
의료진이 편리하고 관리된 약물전달 방법을 찾는 가운데, 세계 경피 흡수형 패치 시장은 꾸준히 성장하고 있습니다. 경피 흡수형 패치는 피부를 통해 약물을 혈류로 직접 전달하여 안정적인 투약과 환자의 복약 순응도를 높입니다. 이 패치는 통증 관리, 호르몬 요법, 금연 및 기타 치료에 널리 사용됩니다.
경피흡수성 피부 패치 시장의 성장에는 몇 가지 요인이 기여하고 있습니다. 만성질환의 유병률 증가와 비침습적 치료법에 대한 수요 증가는 경피적 약물전달 시스템의 사용을 촉진하고 있습니다. 제약사들은 약물의 흡수율과 치료 효과를 향상시킬 수 있는 새로운 패치 제제 개발을 위해 연구개발에 투자하고 있습니다.
약물전달 기술의 발전이 계속되는 가운데, 경피 흡수형 패치 시장의 향후 전망은 밝을 것으로 보입니다. 소재와 패치 디자인의 혁신으로 더 광범위한 약물전달이 가능해질 수 있습니다. 편의성 높은 헬스케어 솔루션과 맞춤형 치료법에 대한 수요 증가는 이 시장의 지속적인 성장을 뒷받침할 것으로 예상됩니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 경피 흡수형 패치 시장 : 유형별
제5장 세계의 경피 흡수형 패치 시장 : 용도별
제6장 세계의 경피 흡수형 패치 시장 : 유통 채널별
제7장 세계의 경피 흡수형 패치 시장 : 지역별
제8장 경쟁 구도
제9장 기업 개요
KSM 26.04.14The Transdermal Skin Patches Market size is expected to reach USD 15.02 Billion in 2034 from USD 9.30 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.
The global transdermal skin patches market has grown steadily as healthcare providers seek convenient and controlled drug delivery methods. Transdermal patches deliver medication through the skin directly into the bloodstream, offering consistent dosing and improved patient compliance. These patches are widely used for pain management, hormone therapy, smoking cessation, and other medical treatments.
Several drivers are contributing to the expansion of the transdermal skin patches market. Increasing prevalence of chronic diseases and growing demand for non-invasive treatment options have encouraged the use of transdermal drug delivery systems. Pharmaceutical companies are investing in research to develop new patch formulations that improve drug absorption and therapeutic effectiveness.
Future prospects for the transdermal skin patches market appear promising as advancements in drug delivery technology continue. Innovations in materials and patch design may enable the delivery of a wider range of medications. Growing demand for convenient healthcare solutions and personalized treatment options is expected to support continued growth in this market.
MARKET SEGMENTATION
By Type
- Single-Layer Drug-In-Adhesive
- Multi-Layer Drug-In-Adhesive
- Matrix
- Other Types
By Application
- Pain Relief
- Smoking Reduction And Cessation Aid
- Cardiovascular Disorders
- Neurological Disorders
- Hormonal Therapy
- Other Applications
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
COMPANIES PROFILED
- Teva Pharmaceutical Industries Ltd, Novartis AG, Teikoku Pharma USA Inc, Viatris Inc, Johnson Johnson, Luye Pharma Group, Purdue Pharma Manufacturing LP, Henan Lingrui Pharmaceutical Co Ltd, Samyang Biopharmaceuticals Corporation, Hisamitsu Pharmaceutical Co Inc
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Type
- 4.2. Single-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Multi-Layer Drug-In-Adhesive Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Matrix Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Pain Relief Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Smoking Reduction And Cessation Aid Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Cardiovascular Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Hormonal Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.7. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Distribution Channel
- 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL TRANSDERMAL SKIN PATCHES MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Type
- 7.2.2 By Application
- 7.2.3 By Distribution Channel
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Type
- 7.3.2 By Application
- 7.3.3 By Distribution Channel
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Type
- 7.4.2 By Application
- 7.4.3 By Distribution Channel
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Type
- 7.5.2 By Application
- 7.5.3 By Distribution Channel
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Type
- 7.6.2 By Application
- 7.6.3 By Distribution Channel
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL TRANSDERMAL SKIN PATCHES INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Teva Pharmaceutical Industries Ltd
- 9.2.2 Novartis AG
- 9.2.3 Teikoku Pharma USA Inc
- 9.2.4 Viatris Inc
- 9.2.5 Johnson & Johnson
- 9.2.6 Luye Pharma Group
- 9.2.7 Purdue Pharma Manufacturing LP
- 9.2.8 Henan Lingrui Pharmaceutical Co. Ltd
- 9.2.9 Samyang Biopharmaceuticals Corporation
- 9.2.10 Hisamitsu Pharmaceutical Co. Inc
